Endologix recently announced that it has received US Food and Drug Administration (FDA) approval for a premarket approval (PMA) supplement relating to the AFX2 system. According to a company press release, Endologix received approval to include an updated warning and the most contemporary clinical information in the labelling for the AFX2 system. Clinical data added […]
The post Endologix receives US FDA approval of PMA supplement for AFX2 system appeared first on Vascular News.
According to a new, population-based analysis, abdominal aortic aneurysm (AAA) mortality has continued to decline and “at a faster rate than ever” in the second decade of the 21st century. Authors C Y Maximilian Png (Massachusetts General Hospital, Boston, USA), Edward Choke (Sengkang General Hospital, Singapore), and colleagues attribute this continued and accelerating decline to […]
The post Large study shows continued and quickening decline in AAA mortality appeared first on Vascular News.
A single-centre, retrospective study reveals that approximately 11% of patients diagnosed with lung cancer concurrently have an abdominal aortic aneurysm (AAA). Researchers theorise dual screening could save lives. There is significant overlap in the populations screened for lung cancer and AAA. The US Preventive Services Task Force (USPSTF) recommends annual screening for lung cancer in […]
The post Study shows that dual screening for lung cancer and AAA could save lives appeared first on Vascular News.